The Fellow on Call: The Heme/Onc Podcast cover image

Episode 078: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - Part 2

The Fellow on Call: The Heme/Onc Podcast

00:00

Exploring Treatment Strategies in Relapsed DLBCL

This chapter explores the latest treatment strategies for relapsed diffuse large B-cell lymphoma, focusing on agents like polotuzumab and tafacetamab. The effectiveness of combination therapies and newer agents, along with their implications in post-CAR-T treatment, are critically analyzed.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app